Incorporation Of Venetoclax Into AML Treatment

Incorporation Of Venetoclax Into AML Treatment

User Photo
obr

1 year
82 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
John Burke, MD, Hematologist/Oncologist and Associate Chair of the US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, discusses Incorporation Of Venetoclax Into AML Treatment. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Up Next Autoplay
>